Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs Livea

AbundRX
Graded #193

Lower grade

vs+3.4000000000000057
Livea
Graded #123

Higher grade

The verdict

Livea takes it — 69.7/100 to 66.3/100.

Livea grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Livea is a physician-supervised medical weight loss clinic founded in 2011 with 8 clinics in MN and WI, plus telehealth in MN, WI, Iowa, and Florida.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +12
66
54
Dose & formulationEven
64
64
Clinical oversightLivea +14
79
93
Labs & monitoringLivea +20
53
73
FulfillmentLivea +5
74
79
Contract termsEven
55
55
AbundRX · left barLivea · right bar

The numbers

MetricAbundRXLivea
WeighScore66.3/10069.7/100
GradeCC
Scorecard rank#193#123
Semaglutide$179/mo (compounded)$99/mo (plus a separate fee, compounded)
Tirzepatide$279/mo (compounded)$199/mo (compounded)
CoverageCoverage not published4 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #193 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Livea

Graded #123 · C

Strengths

  • LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
  • Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
  • Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
  • 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
  • Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible

Where it loses points

  • Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
  • Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
  • Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
  • Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
  • Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard